Overall rank by patents
#3,386
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
West Pharmaceutical Services, Inc.
USPTO PatentsView assignee record — 110 granted patents across 33 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
110
Total patents granted
33
CPC technology areas
10.4
Avg claims per patent
+0%
5-year filing velocity
The verdict
West holds 110 US patents across 33 technology areas — rank #3,386 of 50,000 tracked assignees.
- #3,386
- of 50,000 US assignees by volume
- Top 18%
- by Innovation Score (47.6/100)
- 10.4
- avg claims per patent
- +0%
- filing velocity, last 5 yrs
Portfolio overview
West Pharmaceutical Services, Inc. has been granted 110 US utility patents between 2015 and 2025, placing West Pharmaceutical Services, Inc. at rank #3,386 across all assignees tracked by PlainPatent. This portfolio spans 33 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.4 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, West Pharmaceutical Services, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 47.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 55 grants, compared with 55 in the 2015–2019 window — a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. West Pharmaceutical Services, Inc.'s 10.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 33 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark West Pharmaceutical Services, Inc. against peers pursuing similar technology classes.
How does West compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- West Pharmaceutic… ◀ 110
West Pharmaceutical Services, Inc.
110 patents
What this shows West holds 110 patents — placing it at rank #3,386 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
West's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
48 Top 18% higher than 82% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025
USPTO utility patent grants by year · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 3.6% |
| 2016 | 7 | 6.4% |
| 2017 | 14 | 12.7% |
| 2018 | 10 | 9.1% |
| 2019 | 20 | 18.2% |
| 2020 | 9 | 8.2% |
| 2021 | 13 | 11.8% |
| 2022 | 10 | 9.1% |
| 2023 | 11 | 10.0% |
| 2024 | 9 | 8.2% |
| 2025 | 3 | 2.7% |
Which technologies does West Pharmaceutical Services, Inc. patent most?
Top 15 of 33 technology areas
Patent Moat Analysis
Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Simple
Velocity Growing
Frequently Asked Questions
How many patents does West Pharmaceutical Services, Inc. hold?
West Pharmaceutical Services, Inc. holds 110 US granted patents filed between 2015 and 2025, spanning 33 technology areas.
What is West Pharmaceutical Services, Inc.'s Innovation Score?
West Pharmaceutical Services, Inc. has an Innovation Score of 47.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does West Pharmaceutical Services, Inc. focus on?
West Pharmaceutical Services, Inc.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 53 patents. The company has filed patents in 33 CPC subclasses total.
Is West Pharmaceutical Services, Inc.'s patent filing rate increasing or decreasing?
West Pharmaceutical Services, Inc.'s recent filing velocity is +0% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for West Pharmaceutical Services, Inc.'s patents?
West Pharmaceutical Services, Inc.'s patents average 10.4 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the West Pharmaceutical Services, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
A61M technology
West Pharmaceutical Services, Inc.'s primary CPC class — all holders and yearly trends
Top 50 patent holders
See where West Pharmaceutical Services, Inc. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
